rac Efavirenz-d5 (CAS 154598-52-4)
QUICK LINKS
Rac Efavirenz-d5 is a compound that functions as a non-nucleoside reverse transcriptase inhibitor. It acts by binding to the HIV-1 reverse transcriptase enzyme at the non-nucleoside inhibitor binding site. This binding inhibits the enzyme′s activity, preventing the conversion of viral RNA into DNA. As a result, the replication of the virus is disrupted, ultimately leading to a decrease in viral load. The compound′s mode of action involves inducing conformational changes in the enzyme, thereby interfering with its catalytic function. This disruption of the reverse transcription process hinders the virus′s ability to integrate its genetic material into the host cell′s DNA. Rac Efavirenz-d5 plays a role in inhibiting the replication of HIV-1 at the molecular level, making it a relevant compound for research and development.
rac Efavirenz-d5 (CAS 154598-52-4) References
- Predictors of Efavirenz Plasma Exposure, Auto-Induction Profile, and Effect of Pharmacogenetic Variations among HIV-Infected Children in Ethiopia: A Prospective Cohort Study. | Chala, A., et al. 2021. J Pers Med. 11: PMID: 34945777
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
rac Efavirenz-d5, 1 mg | sc-219826 | 1 mg | $490.00 |